INDIAN BENCHMARKS are likely to open on a cautious note as the global cues look mixed with SGX Nifty trading 12.50 points lower.
Headlines for the day:
Aurobindo Pharma receives USFDA approval for anti-epileptic drug
Biocon's arm Syngene International gets SEBI approval for IPO
TVS Srichakra extends gain on ties up with France's Michelin
Trend in FII flows: The FIIs were net sellers of Rs -604.86 Cr in the cash segment on Monday while the DIIs were net buyers of Rs 650.47 Cr, as per the provisional figures released by the NSE.
Capitalstars is an India's Leading financial advisory company,Our Company Provides tips in an equity & commodity market such as bullion tips,bullion premium tips,mcx tips,premium services etc So take our services and check our premium calls....
0 Comments